Data suggest that cell cycle dysfunction underlies the etiology of GEP-NENs and that different tumor subtypes feature different pathway mutations: mTOR pathway mutations in GEP-NETs, and TP53 and RB pathway mutations in GEP-NECs. Here, RB1 is linked to neoplasm.